Uveal Effusion Reported After Initiation of Anti-PD-1, -PD-L1

THURSDAY, May 10, 2018 -- Patients receiving immunotherapy with antiprogrammed cell death protein-1 (anti-PD-1) and antiprogrammed cell death ligand-1 (anti-PD-L1) monoclonal antibodies may develop uveal effusion, according to a report published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news